Home › Proteinuria › New York
Proteinuria clinical trials in New York
3 studies for Proteinuria are looking for participants at sites in New York.
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Stony Brook Internists PC, East Setauket
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Oct 1, 2026 · NCT05268289A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #27, Valhalla
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07268638Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
- Col Uni Med Center New York Presby, New York
RecruitingPhase 3
Ages 12 to 60 · All sexes · Updated Jul 13, 2026 · NCT05755386From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.